Insulin for All Act of 2023

This bill caps the price of insulin at $20 per 1,000 units for all insulin products approved under federal law (like vials, pens, or cartridges) sold in the United States. It directly affects insulin manufacturers, who must sell at this price, and insulin users, particularly people with diabetes who face high costs. The key provision sets a nationwide price limit, overriding other laws to ensure affordability. This change applies immediately to all covered insulin products without requiring additional regulatory steps.